Stay updated on Pembrolizumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating a minor deployment update. No study content or data are altered.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe Revision label on the page updates from v3.6.3 to v3.6.4, signaling a new build of the page.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision tag has been updated to v3.6.3, replacing the previous v3.6.2. This reflects a minor build/version update.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.6.2 is shown on the page, indicating a new software build. No study content or user-facing information appears to be altered.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now shows recruitment status 'No longer looking for participants' and adds help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment heading from the previous Interventions formatting and revises the page version to v3.6.0.SummaryDifference0.3%

- Check82 days agoChange DetectedThe page shows a new revision: v3.5.5 instead of v3.5.4, indicating a software release. No substantive study details or user-facing content appear to have changed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.